The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.
about
Preventing stem cell transplantation-associated viral infections using T-cell therapyAntiviral T-cell therapyRespiratory syncytial virus infections in infants affected by primary immunodeficiency.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Human rhinovirus C infections in pediatric hematology and oncology patients.Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome Evolution.Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients.Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.Converting everolimus to mycophenolate mofetil ameliorated prolonged respiratory syncytial virus infection in a child after heart transplantation.Respiratory syncytial virus infections in pediatric transplant recipients: A Canadian Paediatric Surveillance Program study.Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Reduction in Rate of Nosocomial Respiratory Virus Infections in a Children's Hospital Associated With Enhanced Isolation Precautions.A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.
P2860
Q26801365-86C59393-D1A0-4CFA-9C7C-CF5EBA4055AFQ27028006-F9AAB657-8CB7-44E6-8204-A65D7F6156B3Q33892605-6116A44D-57DF-4BE7-AC70-4EC296DD6519Q34273968-CCB69B59-524C-4E7F-9859-239BDE726A22Q34791363-4955ED3E-7AD4-4EEE-BCF6-8BDEDE5D2790Q38373552-91DC3233-7786-4BD6-AE23-0871AC0BB1C6Q38609821-82CAFFDC-41B1-4ABC-97FC-6D0F9B095408Q38829076-B3849C40-FA12-4DFB-B764-9A7256CBCB10Q39193577-10B7F194-45EC-4A83-AEF3-788F3CFB7C65Q40095420-8855C351-D297-4712-BF94-8B25B9514B2DQ40760301-E3C26CFE-4AD9-4391-A081-3DF3D762D52BQ41927260-F624A26A-5306-4394-8EE7-422FE3910CB7Q47553977-5BDCA961-ED70-405D-B020-E66C6AFCCF1CQ47589771-A84BE92E-754E-47A1-9BEE-EC29D7E02521
P2860
The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@en
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@nl
type
label
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@en
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@nl
prefLabel
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@en
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@nl
P2093
P2860
P356
P1476
The impact of RSV, adenovirus, ...... plant, or cancer chemotherapy.
@en
P2093
Catherine S Lachenauer
Grace M Lee
Leslie E Lehmann
Mindy S Lo
Nilanthi Gunawardane
Sandra K Burchett
P2860
P304
P356
10.1111/PETR.12022
P577
2012-12-10T00:00:00Z